CEL-SCI Corporation (NYSEMKT:CVM) Hopes That FDA Will Lift The Imposed Clinical Hold After Submitting Its Response
CEL-SCI Corporation (NYSEMKT:CVM) has today announced that it submitted its FDA response. This was in reaction to the recent move by FDA to put hold […]
